Inhalation Sciences Investor Relations Material
Latest events
Q2 2024
Inhalation Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Inhalation Sciences
Access all reports
Inhalation Sciences Sweden AB (ISAB) develops and markets laboratory equipment designed for inhalation research. The company’s primary offerings include systems such as PreciseInhale, which allows scientists to measure how inhaled particles behave in the lungs, and DissolvIt, a tool for in vitro simulation of particle dissolution and absorption in the lung epithelium. Their portfolio also includes specialized modules like XposeALI, for 3D cell exposure, and other equipment used in preclinical testing of inhalation drugs and toxicity studies. Inhalation Sciences serves industries involved in respiratory medicine, toxicology, and aerosol science. The company is headquartered in Huddinge, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
Deere & Company: Shaping the Future of Agriculture Since 1837
Detailing the history of agriculture and Deere & Company, all the way from 1837 to the present day.
25 Oct 2024
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Ticker symbol
ISAB
Country
🇸🇪 Sweden